Kelly Thomas Patrick bought XENE
October 15, 2026 · Form 4 insider transaction
Kelly Thomas Patrick bought 7,500 shares of Xenon Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
N/A
Total value
N/A
InsiderKelly Thomas Patrick
RoleOfficer
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateOctober 15, 2026
Filing dateOctober 16, 2026
Shares owned after22,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on October 15, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on October 15, 2026.